FDA recall D-1057-2020

Mylan Pharmaceuticals Inc. · Class III · drug

Product

Tacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2047-01

Reason for recall

Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.

Distribution

U.S.A. Nationwide

Key facts

Status
Terminated
Initiation date
2020-03-23
Report date
2020-04-01
Termination date
2021-07-07
Voluntary/Mandated
Voluntary: Firm initiated
Location
Morgantown, WV, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1057-2020